Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.
AUTOR(ES)
Shawar, R
RESUMO
Ceftibuten is a new orally active cephalosporin with significant bioavailability. Its in vitro activity was compared with those of other agents against 383 strains of enteric pathogens derived from clinical specimens. Ceftibuten was very active against the strains of the family Enterobacteriaceae tested (overall MIC for 90% of strains tested, 0.25 microgram/ml) but was less active against Campylobacter jejuni (MIC for 90% of strains, 16 micrograms/ml). The MBC was one to two dilutions higher than the corresponding MICs for most pathogens tested.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172535Documentos Relacionados
- Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
- Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
- Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.
- Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
- Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.